Recent Updates
Recently added Catalysts
PTCT Neutral Sentiment

PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2022 Financial Results PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its fourth quarter and full year ...

Tuesday, February 7, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: PTC Therapeutics, Inc. has announced a conference call to discuss its financial results for the fourth quarter and full year of 2022. The call is scheduled for February 21, 2023, at 4:30 p.m. ET and will be accessible via phone and webcast. A replay of the call will also be available for 30 days post-event, providing further insights into the company's performance and outlook.
Price reaction · baseline $46.23 (2023-02-06 close) · hit after-hours · clean, no other PTCT news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is providing a financial update.
  • The company has scheduled a conference call for stakeholders.
  • Access to the call is readily available via multiple platforms.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

SOUTH PLAINFIELD, N.J. , Feb. 7, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that the company will host a webcast conference call to report its fourth quarter and full year 2022 financial results and provide an update on the company's business and outlook on Tuesday, Feb. 21 , at 4:30 p.m. ET .
To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations . A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.
For More Information:

Frequently Asked Questions

When will PTC Therapeutics report their financial results?

PTC Therapeutics will report its financial results on Feb. 21, 2023, at 4:30 p.m. ET.

How can I access the conference call?

You can register for dial-in details or access the call on PTC's Investor website.

Is there a replay of the conference call?

Yes, a replay will be available two hours after the call and archived for 30 days.

Who should I contact for investor inquiries?

For inquiries, contact Kylie O'Keefe at +1 (908) 300-0691.

What is the purpose of the call on February 21?

The call will discuss PTC's financial results and provide a business outlook.

ShareAdd on Google
Tags: PTCT Viatris Investor Conferences Healthcare PTC Therapeutics financial results conference call Q4 2022 NASDAQ: PTCT
Last updated: Feb 7, 2023

Biotech snapshot

Cash runway
$2229M liquidity · $0M/mo burn
Low dilution risk
Lead asset
AtalurenPhase 3
Cystic Fibrosis →

Catalyst track record

+74%
best trade around PTCT's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for PTCT.

See every catalyst's timing & PoA →